Hematological Oncology (HO)

Hematological Oncology is a peer‑reviewed scientific journal that bridges the clinical and experimental aspects of hematologic cancers and related neoplastic diseases of the blood and lymphoid systems. Established in 1983, the journal has become an important publication platform for research that advances knowledge of leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and other malignant hematologic conditions. The journal publishes original research articles, clinical studies, translational science reports, and review papers that contribute to understanding disease mechanisms, diagnostic innovations, therapeutic strategies, and outcomes research in hematology and oncology. It emphasizes studies that apply foundational laboratory science to clinical applications — including biomarker discovery, molecular genetics, cytogenetics, stem cell biology, and novel treatments such as targeted therapies and immunotherapies. Published by Wiley, Hematological Oncology reaches an international audience of clinicians, researchers, and specialists in cancer biology and blood disorders. Its quarterly issues (compiled from continuous publishing) ensure timely dissemination of advances spanning basic science to clinical practice. While the chief editorial leadership is provided by a team of experts — most notably Francesco Bertoni in influential editor functions — the journal encourages authors to use the official Wiley submission system for editorial correspondence.

Hematological Oncology (HO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Oncology, Hematology, General Medicine, Medical research focused on hematology and oncology, leukemias, lymphomas, myeloproliferative disorders, diagnostics, pathology, cellular and molecular biology , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0278-0232, E-ISSN: 1099-1069, Established: 1983, Impact Factor: 3.9
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE